Extracellular Vesicles: Biology and Their Use as Potential Biomarkers in Hematopoietic Post-Transplant Complications

Giuseppe Lia(University of Turin), Luisa Giaccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Irene Dogliotti(Unknown), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Giulia Gabrielli(Hospital of the University of Pennsylvania), Aurora Martín(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jessica Gill(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Elsevier eBooks
January 1, 2024
10.1016/b978-0-443-15717-2.00099-8
Cited by 0

Related Papers

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
|Blood|2003|407
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
|Blood|2023|330
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
|JAMA|2011|323
Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning
|Journal of Clinical Oncology|2008|278
Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34+ bone marrow cells
|Blood|2000|270